实名注册领 50MDS,邀请再领 250MDS
Sign up & complete identity verification: 50MDS
Refer a friend: 10MDS (up to 250MDS)
MediShares (MDS) 社区简介

MediShares 是世界上第一个相互保障合约市场,基于区块链技术提供相互保障智能合约创建和使用平台,有效降低保障产品的运营成本,同时提供更高的保障资金安全性。

目前 MDS 已上线 huobi.pro , gate.io , CEX.comOTCBTC.com

MediShares (MDS) Community Introduction

MediShares is the first global mutual insurance marketplace on the blockchain. It combines the traditional mutual insurance model with blockchain and smart contract which provides a low operation cost and high guarantee of capital security.

Listed on huobi.pro , gate.io , CEX.com and OTCBTC.com .

活动细则
  1. 活动开启时间:2017 年 12 月 20 日 00:00,预计 MediShares App 上线时间:2018 年 3 月;
  2. 用户注册并完成实名认证即可领 50MDS,如邀请 1 名好友并通过实名认证,可再领取 10MDS,邀请奖励最高 250MDS;
  3. 本次活动领取的 MDS 暂时处于锁定状态,待 MediShares App 正式上线后将分期逐步解锁并领取,逾期未领取的 MDS 将会被系统回收,领取后的 MDS 可自由流通;
  4. 本次活动的 MDS 总量有限,领取数量将逐步减少到活动正式终止;
  5. 对活动如有任何疑问,请关注微信公众号「MediShares」进行咨询;
  6. 活动期间,如发现用户涉及违规操作,MediShares 有权取消该用户活动资格,必要时关闭其 MediShares 账户并追究其法律责任;
  7. 其他未明确事项以 MediShares 官方公告为准,MediShares 将根据实际情况对活动进行调整,最终解释权归 MediShares 所有。
Activity detail
  1. Activity starts date: 2017/12/20 00:00 GMT+8. Expected launch date of the APP: March, 2018.
  2. Each user will get 50 MDS by signing up & completing identity verification. Earn extra I0MDS by referring a friend (up to 250MDS).
  3. The MDS earned in this activity will be locked until the MDS APP officially released and should be claimed within a valid period. Otherwise the system will retrieve the unclaimed tokens. The claimed tokens could be free traded in the market.
  4. The number of the free tokens of this activity is limited.
  5. If you have any questions, feel free to connect us through our Official Website or via Telegram (can be reached at the end of our official website).
  6. Any user violates this statement or our policies will lose his qualification for the activity.
  7. To the other undefined conditions, the official announcement of MediShares controls and would adjust rule according to actual situation. MediShares reserves the right of final interpretation.